U.S. Mycoplasma Testing Market Size & Outlook, 2023-2030

The mycoplasma testing market in the United States is expected to reach a projected revenue of US$ 754.2 million by 2030. A compound annual growth rate of 12.9% is expected of the United States mycoplasma testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$323.2
Forecast, 2030 (US$M)
$754.2
CAGR, 2024 - 2030
12.9%
Report Coverage
U.S.

U.S. mycoplasma testing market highlights

  • The U.S. mycoplasma testing market generated a revenue of USD 323.2 million in 2023 and is expected to reach USD 754.2 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 12.9% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Mycoplasma testing market data book summary

Market revenue in 2023USD 323.2 million
Market revenue in 2030USD 754.2 million
Growth rate12.9% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Kits & Reagents, Services
Key market players worldwideThermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen


Other key industry trends

  • In terms of revenue, U.S. accounted for 34.2% of the global mycoplasma testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. mycoplasma testing market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 126.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mycoplasma Testing Market Companies

Name Profile # Employees HQ Website

U.S. mycoplasma testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 56.22% in 2023. Horizon Databook has segmented the U.S. mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. market for mycoplasma testing is expected to witness lucrative growth as it is the biggest market for biotechnology & biopharmaceuticals and a leader in biopharmaceutical R&D. According to data published by PhRMA in 2018, the U.S. biopharmaceutical industry invested around USD 102 billion in R&D activities.

Furthermore, the high prevalence of chronic diseases like cancer and extensive R&D activities by regional players for developing novel cell & gene therapies are expected to fuel the demand for cell culture solutions, which will likely drive the demand for mycoplasma testing over the forecast period. As per the American Cancer Society, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer-related deaths.

In addition, following the outbreak of COVID‐19, several U.S.-based companies were involved in extensive research for the development of novel vaccines & therapeutics, driving the demand for mycoplasma testing solutions for quality control applications.

Reasons to subscribe to U.S. mycoplasma testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. mycoplasma testing market databook

  • Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. mycoplasma testing market size, by product, 2018-2030 (US$M)

U.S. Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)

U.S. mycoplasma testing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more